WASHINGTON (AP) -- Federal regulators warned Ligand Pharmaceuticals today that promotional materials used to market two drugs it recently sold to another company are misleading because they misstate the risks and effectiveness of the products.
WASHINGTON (AP) -- Federal regulators warned Ligand Pharmaceuticals today that promotional materials used to market two drugs it recently sold to another company are misleading because they misstate the risks and effectiveness of the products.
